REFERENCES
- Achari, A., Somers, D. O., Champness, J. N., Bryant, P. K., Rosenmond, J. & Stammers, D. K. (1997). Nature Structural Biology, 4, 490–497.
- Brown, G. M. (1962). Journal of Biological Chemistry, 237, 536–540.
- Chae, G. T. (2000). Korean Leprosy Bulletin, 33, 1–19.
- Fermer, C. & Swedberg, G. (1997). Journal of Bacteriology, 179, 831–837.
- Ji, B. (1985). International Journal of Leprosy, 56, 265–278.
- Kai, M., Matsuoka, M., Nakata, N., Maeda, S., Gidoh, M., Maeda, Y., Hashimoto, K., Kobayashi, K. & Kashiwabara, Y. (1999). FEMS Microbiology Letters, 177, 231–235.
- Kim, D. I. (1983). Korean Leprosy Bulletin, 16, 49–56.
- Richey, D. P. & Brown, G. M. (1969). Journal of Biological Chemistry, 244, 1582–1592.
- Swedberg, G., Ringertz, S. & Skold, O. (1998). Antimicrobial Agents and Chemotherapy, 42, 1062–1067.
- Vedantam, G., Guay, G. G., Austria, N. E., Doktor, S. Z. & Nichols, B. P. (1998). Antimicrobial Agents and Chemotherapy, 42, 88–93.
- Williams, D., Spring, L., Harris, E., Roche, P. & Gillis, T. P. (2000). Antimicrobial Agents and Chemotherapy, 44, 1530–1537.
- Woods, S. A. & Cole, S. T. (1989). FEMS Microbiology Letters, 53, 305–310.
- World Health Organization (1982). Chemotherapy of Leprosy for Control Programmes. Report of a WHO Study Group. Technical Report Series No. 675. Geneva: WHO.